For the first time, a team of Chinese scientists will use the CRISPR-Cas9 gene editing technique in a clinical trial on lung cancer patients. The clinical trial is expected to begin next month.
For the first time, a team of Chinese scientists will use the CRISPR-Cas9 gene editing technique in a clinical trial on lung cancer patients. The clinical trial is expected to begin next month.